Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9438318rdf:typepubmed:Citationlld:pubmed
pubmed-article:9438318lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:9438318lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:9438318lifeskim:mentionsumls-concept:C0034196lld:lifeskim
pubmed-article:9438318lifeskim:mentionsumls-concept:C0231175lld:lifeskim
pubmed-article:9438318lifeskim:mentionsumls-concept:C0205250lld:lifeskim
pubmed-article:9438318lifeskim:mentionsumls-concept:C1704419lld:lifeskim
pubmed-article:9438318pubmed:issue12lld:pubmed
pubmed-article:9438318pubmed:dateCreated1998-3-19lld:pubmed
pubmed-article:9438318pubmed:abstractTextIn this study we compared the cure rates of two clarithromycin-based regimens in patients in whom anti-Helicobacter pylori therapy had previously failed.lld:pubmed
pubmed-article:9438318pubmed:languageenglld:pubmed
pubmed-article:9438318pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9438318pubmed:citationSubsetIMlld:pubmed
pubmed-article:9438318pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9438318pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9438318pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9438318pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9438318pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9438318pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9438318pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9438318pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9438318pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9438318pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9438318pubmed:statusMEDLINElld:pubmed
pubmed-article:9438318pubmed:monthDeclld:pubmed
pubmed-article:9438318pubmed:issn0036-5521lld:pubmed
pubmed-article:9438318pubmed:authorpubmed-author:FáraMMlld:pubmed
pubmed-article:9438318pubmed:authorpubmed-author:MotzPPlld:pubmed
pubmed-article:9438318pubmed:authorpubmed-author:BergeTTlld:pubmed
pubmed-article:9438318pubmed:authorpubmed-author:TønnesenTTlld:pubmed
pubmed-article:9438318pubmed:authorpubmed-author:ToroSSlld:pubmed
pubmed-article:9438318pubmed:authorpubmed-author:LerangFFlld:pubmed
pubmed-article:9438318pubmed:authorpubmed-author:TolåsPPlld:pubmed
pubmed-article:9438318pubmed:authorpubmed-author:SandveiP KPKlld:pubmed
pubmed-article:9438318pubmed:issnTypePrintlld:pubmed
pubmed-article:9438318pubmed:volume32lld:pubmed
pubmed-article:9438318pubmed:ownerNLMlld:pubmed
pubmed-article:9438318pubmed:authorsCompleteYlld:pubmed
pubmed-article:9438318pubmed:pagination1209-14lld:pubmed
pubmed-article:9438318pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9438318pubmed:meshHeadingpubmed-meshheading:9438318-...lld:pubmed
pubmed-article:9438318pubmed:meshHeadingpubmed-meshheading:9438318-...lld:pubmed
pubmed-article:9438318pubmed:meshHeadingpubmed-meshheading:9438318-...lld:pubmed
pubmed-article:9438318pubmed:meshHeadingpubmed-meshheading:9438318-...lld:pubmed
pubmed-article:9438318pubmed:meshHeadingpubmed-meshheading:9438318-...lld:pubmed
pubmed-article:9438318pubmed:meshHeadingpubmed-meshheading:9438318-...lld:pubmed
pubmed-article:9438318pubmed:meshHeadingpubmed-meshheading:9438318-...lld:pubmed
pubmed-article:9438318pubmed:meshHeadingpubmed-meshheading:9438318-...lld:pubmed
pubmed-article:9438318pubmed:meshHeadingpubmed-meshheading:9438318-...lld:pubmed
pubmed-article:9438318pubmed:meshHeadingpubmed-meshheading:9438318-...lld:pubmed
pubmed-article:9438318pubmed:meshHeadingpubmed-meshheading:9438318-...lld:pubmed
pubmed-article:9438318pubmed:meshHeadingpubmed-meshheading:9438318-...lld:pubmed
pubmed-article:9438318pubmed:meshHeadingpubmed-meshheading:9438318-...lld:pubmed
pubmed-article:9438318pubmed:meshHeadingpubmed-meshheading:9438318-...lld:pubmed
pubmed-article:9438318pubmed:meshHeadingpubmed-meshheading:9438318-...lld:pubmed
pubmed-article:9438318pubmed:meshHeadingpubmed-meshheading:9438318-...lld:pubmed
pubmed-article:9438318pubmed:meshHeadingpubmed-meshheading:9438318-...lld:pubmed
pubmed-article:9438318pubmed:meshHeadingpubmed-meshheading:9438318-...lld:pubmed
pubmed-article:9438318pubmed:meshHeadingpubmed-meshheading:9438318-...lld:pubmed
pubmed-article:9438318pubmed:meshHeadingpubmed-meshheading:9438318-...lld:pubmed
pubmed-article:9438318pubmed:meshHeadingpubmed-meshheading:9438318-...lld:pubmed
pubmed-article:9438318pubmed:year1997lld:pubmed
pubmed-article:9438318pubmed:articleTitleHighly effective second-line anti-Helicobacter pylori therapy in patients with previously failed metronidazole-based therapy.lld:pubmed
pubmed-article:9438318pubmed:affiliationDept. of Internal Medicine, Ostfold Central Hospital, Fredrikstad, Norway.lld:pubmed
pubmed-article:9438318pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9438318pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:9438318pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:9438318pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:9438318pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:9438318pubmed:publicationTypeClinical Trial, Phase IIlld:pubmed
pubmed-article:9438318pubmed:publicationTypeClinical Trial, Phase Illd:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9438318lld:pubmed